A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.

Trial Profile

A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 May 2018

At a glance

  • Drugs Terbinafine (Primary)
  • Indications Onychomycosis
  • Focus Pharmacokinetics
  • Sponsors Moberg Pharma
  • Most Recent Events

    • 02 May 2018 Status changed from active, no longer recruiting to completed.
    • 05 Apr 2018 Status changed from recruiting to active, no longer recruiting.
    • 23 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top